Daniel Haverstock
Bayer (United States)(US)
Publications by Year
Research Areas
Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy, Respiratory and Cough-Related Research, Urinary Tract Infections Management, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Results of a Randomized Trial Comparing Sequential Intravenous/Oral Treatment with Ciprofloxacin Plus Metronidazole to Imipenem/Cilastatin for Intra-Abdominal Infections(1996)191 cited
- → Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomized trial(1995)173 cited
- → Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis(2000)136 cited
- → Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis(1999)107 cited
- → Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis(2011)99 cited
- → Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections(2000)95 cited
- → Cystic fibrosis clinical score: A new scoring system to evaluate acute pulmonary exacerbation(1999)80 cited
- → Moxifloxacinversusamoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results(2011)74 cited
- → Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations(1997)73 cited
- → Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women(2002)65 cited